HK1202815A1 - 醋酸鈣的液體組合物 - Google Patents
醋酸鈣的液體組合物Info
- Publication number
- HK1202815A1 HK1202815A1 HK15103511.7A HK15103511A HK1202815A1 HK 1202815 A1 HK1202815 A1 HK 1202815A1 HK 15103511 A HK15103511 A HK 15103511A HK 1202815 A1 HK1202815 A1 HK 1202815A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- calcium acetate
- liquid compositions
- individual
- sweetener
- administering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83209306P | 2006-07-21 | 2006-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1202815A1 true HK1202815A1 (zh) | 2015-10-09 |
Family
ID=38957385
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09109755.7A HK1129814A1 (en) | 2006-07-21 | 2009-10-21 | Liquid compositions of calcium acetate |
HK15103511.7A HK1202815A1 (zh) | 2006-07-21 | 2015-04-10 | 醋酸鈣的液體組合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09109755.7A HK1129814A1 (en) | 2006-07-21 | 2009-10-21 | Liquid compositions of calcium acetate |
Country Status (18)
Country | Link |
---|---|
US (3) | US8591938B2 (zh) |
EP (2) | EP2484352B1 (zh) |
JP (1) | JP5335674B2 (zh) |
KR (1) | KR101553719B1 (zh) |
CN (2) | CN101522021B (zh) |
AT (1) | ATE547099T1 (zh) |
AU (1) | AU2007275606B9 (zh) |
BR (1) | BRPI0714882A2 (zh) |
CA (1) | CA2658465C (zh) |
ES (1) | ES2382993T3 (zh) |
HK (2) | HK1129814A1 (zh) |
IL (1) | IL196584A0 (zh) |
MX (1) | MX2009000722A (zh) |
NZ (1) | NZ574331A (zh) |
PL (2) | PL2048948T3 (zh) |
RU (1) | RU2463060C2 (zh) |
WO (1) | WO2008011126A2 (zh) |
ZA (1) | ZA200900472B (zh) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2574777C (en) * | 2004-07-23 | 2015-09-01 | Acceleron Pharma Inc. | Actrii receptor polypeptides, methods and compositions |
US8128933B2 (en) | 2005-11-23 | 2012-03-06 | Acceleron Pharma, Inc. | Method of promoting bone growth by an anti-activin B antibody |
EP1973559B1 (en) | 2005-11-23 | 2013-01-09 | Acceleron Pharma Inc. | Activin-actriia antagonists and uses for promoting bone growth |
CA2658465C (en) | 2006-07-21 | 2016-06-14 | Stephen C. Tarallo | Liquid compositions of calcium acetate |
RS52537B (en) * | 2006-12-18 | 2013-04-30 | Acceleron Pharma Inc. | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR ANEMIA TREATMENT |
US20100028332A1 (en) * | 2006-12-18 | 2010-02-04 | Acceleron Pharma Inc. | Antagonists of actriib and uses for increasing red blood cell levels |
US8895016B2 (en) * | 2006-12-18 | 2014-11-25 | Acceleron Pharma, Inc. | Antagonists of activin-actriia and uses for increasing red blood cell levels |
TWI480048B (zh) * | 2007-02-01 | 2015-04-11 | Acceleron Pharma Inc | 活化素-ActRIIa拮抗劑及其治療或預防乳癌之用途 |
TW201627320A (zh) * | 2007-02-02 | 2016-08-01 | 艾瑟勒朗法瑪公司 | 衍生自ActRIIB的變體與其用途 |
TW201808334A (zh) * | 2007-02-09 | 2018-03-16 | 艾瑟勒朗法瑪公司 | 包含ActRIIa-Fc融合蛋白的醫藥組合物;ActRIIa-Fc融合蛋白於治療或預防與癌症相關的骨質流失之用途;ActRIIa-Fc融合蛋白於治療或預防多發性骨髓瘤之用途 |
EP2207562B1 (en) * | 2007-09-18 | 2017-05-31 | Acceleron Pharma, Inc. | Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion |
CA2729100C (en) * | 2008-06-26 | 2018-01-02 | Acceleron Pharma Inc. | Methods for dosing an activin-actriia antagonist and monitoring of treated patients |
KR20110031951A (ko) * | 2008-06-26 | 2011-03-29 | 악셀레론 파마 인코포레이티드 | 액티빈-actriia의 길항물질 및 적혈구 수준을 증가시키기 위한 이들의 용도 |
TW201803586A (zh) * | 2008-08-14 | 2018-02-01 | 艾瑟勒朗法瑪公司 | 使用gdf阱以增加紅血球水平 |
US8216997B2 (en) | 2008-08-14 | 2012-07-10 | Acceleron Pharma, Inc. | Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators |
US8138142B2 (en) * | 2009-01-13 | 2012-03-20 | Acceleron Pharma Inc. | Methods for increasing adiponectin in a patient in need thereof |
EP3345921A1 (en) | 2009-06-08 | 2018-07-11 | Acceleron Pharma Inc. | Use of anti-actriib antibodies for increasing thermogenic adipocytes |
ES2836534T3 (es) | 2009-06-12 | 2021-06-25 | Acceleron Pharma Inc | Proteínas de fusión de ActRIIB-Fc truncadas |
JP6211767B2 (ja) * | 2009-09-09 | 2017-10-11 | アクセルロン ファーマ, インコーポレイテッド | ActRIIbアンタゴニストならびにその投薬および使用 |
CA2779472C (en) * | 2009-11-03 | 2021-03-16 | Acceleron Pharma Inc. | The use of a composition comprising an activin type iib receptor polypeptide in the treatment of fatty liver disease |
ES2658292T3 (es) | 2009-11-17 | 2018-03-09 | Acceleron Pharma, Inc. | Proteínas ActRIIB y variantes y usos de las mismas con respecto a la inducción de la utrofina para el tratamiento de la distrofia muscular |
JP5766021B2 (ja) * | 2010-05-14 | 2015-08-19 | 興和株式会社 | 安定な水性液剤 |
EP2441436A1 (de) | 2010-10-13 | 2012-04-18 | Fresenius Medical Care Deutschland GmbH | Phosphatbinderformulierung zur einfachen Einnahme |
CA2817008A1 (en) | 2010-11-08 | 2012-05-18 | Acceleron Pharma Inc. | Actriia binding agents and uses thereof |
BE1019709A3 (fr) * | 2010-12-22 | 2012-10-02 | Calxx Laboratoires S A | Produit alimentaire organo-mineral et procede de preparation. |
US9149529B2 (en) * | 2012-10-24 | 2015-10-06 | Orthovita, Inc. | Stable compositions containing thrombin and methods for preparation and use thereof |
CN104936605A (zh) | 2012-11-02 | 2015-09-23 | 细胞基因公司 | 激活素-actrii拮抗剂和用于治疗骨和其它病症的用途 |
WO2015192111A1 (en) | 2014-06-13 | 2015-12-17 | Acceleron Pharma, Inc. | Methods and compositions for treating ulcers |
MA41052A (fr) | 2014-10-09 | 2017-08-15 | Celgene Corp | Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii |
KR102556991B1 (ko) | 2014-12-03 | 2023-07-19 | 셀진 코포레이션 | 액티빈-ActRII 길항제 및 빈혈 치료를 위한 용도 |
CN104688681B (zh) * | 2015-03-17 | 2018-01-02 | 常州康普药业有限公司 | 利巴韦林口服液及其制备方法 |
JP6718212B2 (ja) * | 2015-08-17 | 2020-07-08 | 三菱商事ライフサイエンス株式会社 | 酢酸カルシウムのえぐ味抑制方法 |
GB2551971B (en) * | 2016-06-29 | 2020-09-16 | Syri Ltd | Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof |
WO2020150460A1 (en) * | 2019-01-18 | 2020-07-23 | Milne Iii Donald A | Micronized aspirin formulation |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4093710A (en) * | 1976-07-07 | 1978-06-06 | Sandoz, Inc. | Rapid dissolving effervescent granules |
US5095035A (en) * | 1981-07-31 | 1992-03-10 | Eby Iii George A | Flavor stable zinc acetate compositions for oral absorption |
JPS6136222A (ja) | 1984-07-26 | 1986-02-20 | Chugai Pharmaceut Co Ltd | 高リン酸血症治療剤 |
GB8629781D0 (en) | 1986-12-12 | 1987-01-21 | Glaxo Group Ltd | Pharmaceutical compositions |
US4870105B1 (en) * | 1987-04-07 | 1998-03-10 | Braintree Lab | Phosphorus binder |
CN1067250A (zh) | 1991-05-28 | 1992-12-23 | 北京师范大学 | 桐酸系间苯二酚甲醛树脂的合成方法 |
DE19528524C2 (de) * | 1995-08-03 | 1999-11-11 | Hans Dietl | Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung |
US5763449A (en) | 1996-08-07 | 1998-06-09 | Ascent Pediatrics, Inc. | Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
US5833954A (en) * | 1996-08-20 | 1998-11-10 | American Dental Association Health Foundation | Anti-carious chewing gums, candies, gels, toothpastes and dentifrices |
CN1162489A (zh) | 1997-02-25 | 1997-10-22 | 青岛盖宝特保健品有限公司 | 酪磷肽钙营养液 |
CN1067250C (zh) | 1997-08-21 | 2001-06-20 | 中国人民解放军总装备部后勤部军事医学研究所 | 中性补钙制剂 |
US5976507A (en) * | 1998-06-04 | 1999-11-02 | Colgate Palmolive Company | Dentrifice composition containing encapsulated reactive ingredients |
US5858333A (en) * | 1998-08-07 | 1999-01-12 | Enamelon, Inc. | Two-part oral products and methods of using same to remineralize teeth |
DE19917705C1 (de) | 1999-04-20 | 2000-12-28 | Vitasyn Gmbh | Mittel zur Therapie von Hyperphosphatämie |
CN1242963A (zh) | 1999-07-26 | 2000-02-02 | 李久成 | 补钙可乐及其制备方法 |
CN1252278A (zh) | 1999-09-16 | 2000-05-10 | 冯荣根 | 锌钙海狸营养品 |
JP2001204440A (ja) * | 2000-01-25 | 2001-07-31 | Mitsukan Group Honsha:Kk | カルシウム飲料 |
IL154307A0 (en) | 2000-08-07 | 2003-09-17 | Ranbaxy Signature Llc | Liquid formulation of metformin |
CN1159993C (zh) | 2000-10-26 | 2004-08-04 | 李久成 | 一种强化多元素离子饮料及其制备方法 |
US6576665B2 (en) | 2001-04-03 | 2003-06-10 | Braintree Laboratories, Inc. | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
US20030026872A1 (en) * | 2001-05-11 | 2003-02-06 | The Procter & Gamble Co. | Compositions having enhanced aqueous solubility and methods of their preparation |
WO2002096393A1 (en) | 2001-05-29 | 2002-12-05 | Potchefstroom University For Christian Higher Education | Anorexic composition comprising calcium acetate |
JP2002363105A (ja) * | 2001-05-31 | 2002-12-18 | Taiho Yakuhin Kogyo Kk | 不快な味のマスキング方法及び内服用液剤 |
ITMI20011284A1 (it) * | 2001-06-19 | 2002-12-19 | Salvatore Bilardello | Composizione farmaceutica per il trattamento dell'iperfosfatemia |
US6887897B2 (en) | 2001-07-31 | 2005-05-03 | Mission Pharmacal Company | Calcium glutarate supplement and phosphorus binder |
US7101572B2 (en) * | 2001-12-07 | 2006-09-05 | Unilab Pharmatech, Ltd. | Taste masked aqueous liquid pharmaceutical composition |
GB2395124A (en) | 2002-11-16 | 2004-05-19 | Fluid Technologies Plc | Palatable microcapsules |
EP1565153A4 (en) | 2002-11-22 | 2008-10-01 | Noville Inc | ORAL COMPOSITIONS MASKING SALT FLAVOR SALT |
UA86816C2 (uk) * | 2004-06-01 | 2009-05-25 | Нікомед Фарма Ас | Таблетка для жування, смоктання та ковтання, яка містить кальційвмісну сполуку як активну речовину і цукровий спирт |
GB2416981A (en) | 2004-08-13 | 2006-02-15 | Nutraceuticals Ltd | Premixes, flour enriched with same, mineral supplemented foodstuffs and methods of manufacture therefore. |
US7862836B2 (en) * | 2005-04-12 | 2011-01-04 | Biolink Life Sciences, Inc. | Phosphorus binder for treatment of kidney disease |
CA2658465C (en) | 2006-07-21 | 2016-06-14 | Stephen C. Tarallo | Liquid compositions of calcium acetate |
-
2007
- 2007-07-20 CA CA2658465A patent/CA2658465C/en not_active Expired - Fee Related
- 2007-07-20 PL PL07836163T patent/PL2048948T3/pl unknown
- 2007-07-20 AU AU2007275606A patent/AU2007275606B9/en not_active Ceased
- 2007-07-20 EP EP11192965.9A patent/EP2484352B1/en not_active Not-in-force
- 2007-07-20 AT AT07836163T patent/ATE547099T1/de active
- 2007-07-20 NZ NZ574331A patent/NZ574331A/en not_active IP Right Cessation
- 2007-07-20 JP JP2009520849A patent/JP5335674B2/ja not_active Expired - Fee Related
- 2007-07-20 CN CN200780034340.4A patent/CN101522021B/zh not_active Expired - Fee Related
- 2007-07-20 KR KR1020097003199A patent/KR101553719B1/ko not_active IP Right Cessation
- 2007-07-20 RU RU2009104774/15A patent/RU2463060C2/ru not_active IP Right Cessation
- 2007-07-20 CN CN201410289567.5A patent/CN104095838A/zh active Pending
- 2007-07-20 PL PL11192965T patent/PL2484352T3/pl unknown
- 2007-07-20 BR BRPI0714882-8A patent/BRPI0714882A2/pt not_active IP Right Cessation
- 2007-07-20 WO PCT/US2007/016415 patent/WO2008011126A2/en active Application Filing
- 2007-07-20 MX MX2009000722A patent/MX2009000722A/es active IP Right Grant
- 2007-07-20 ES ES07836163T patent/ES2382993T3/es active Active
- 2007-07-20 US US11/878,169 patent/US8591938B2/en active Active
- 2007-07-20 EP EP07836163A patent/EP2048948B1/en not_active Not-in-force
-
2009
- 2009-01-19 IL IL196584A patent/IL196584A0/en active IP Right Grant
- 2009-01-21 ZA ZA200900472A patent/ZA200900472B/xx unknown
- 2009-10-21 HK HK09109755.7A patent/HK1129814A1/xx not_active IP Right Cessation
-
2011
- 2011-06-17 US US13/162,938 patent/US8592480B2/en active Active
-
2013
- 2013-10-14 US US14/053,126 patent/US9089528B2/en not_active Expired - Fee Related
-
2015
- 2015-04-10 HK HK15103511.7A patent/HK1202815A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1202815A1 (zh) | 醋酸鈣的液體組合物 | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
WO2008011363A3 (en) | Quercetin-containing compositions | |
WO2007117778A8 (en) | Quinolones useful as inducible nitric oxide synthase inhibitors | |
IL195030A (en) | IV dpp inhibitor assemblies | |
WO2007052023A3 (en) | Novel compounds | |
TW200612892A (en) | Novel compounds | |
WO2007068894A3 (en) | Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease | |
WO2009153665A3 (en) | Inhibitors of the shiga toxins trafficking through the retrograde pathway | |
TW200630336A (en) | Novel compounds | |
TW200745003A (en) | Novel compounds | |
TW200621690A (en) | Novel compounds | |
WO2007135241A3 (en) | Composition and method for binding acetaldehyde in stomach | |
WO2008017346A3 (de) | Ascorbinsäurederivate, verwendung zur funktionalisierung von matrices | |
WO2007144778A3 (en) | Herbal compositions for the prevention or treatment of a urinary tract infection | |
WO2009100275A3 (en) | Compositions and devices | |
WO2007130821A3 (en) | Mglur5 modulators ii | |
UA102254C2 (ru) | Жидкий состав для деферипрона с приятным вкусом | |
WO2012075015A3 (en) | Oral metronidazole pharmaceutical compositions | |
WO2008033935A3 (en) | Vinorelbine derivatives | |
WO2010121213A3 (en) | Antibacterial compositions | |
WO2007104933A8 (en) | Chemical compounds | |
MY147271A (en) | Accelerating agent of calcium absorption | |
TNSN08242A1 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
WO2007089315A3 (en) | Chewing gum composition including free, unencapsulated neotame and encapsulated high-intensity sweetener |